Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3077 |
|
Actual shortage: | 235 (8%) | |
Anticipated shortage: | 16 (1%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2817 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-CEFACLOR | 500MG | CAPSULE | Actual shortage | 2017-08-13 | 2017-10-05 | 19039 |
APO-DOCUSATE CALCIUM | 240MG | CAPSULE | Actual shortage | 2017-08-14 | 2017-10-05 | 19120 |
APO-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2017-08-14 | 2017-12-07 | 19129 |
APO AMPI CAPSULES 250MG | 250MG | CAPSULE | Actual shortage | 2017-08-16 | 2017-10-05 | 19582 |
APO AMPI CAPSULES 500MG | 500MG | CAPSULE | Actual shortage | 2017-08-16 | 2017-10-05 | 19589 |
APO-GABAPENTIN | 100MG | CAPSULE | Resolved | 2017-08-21 | 2017-10-04 | 20000 |
APO-DOXY CAP 100MG | 100MG | CAPSULE | Resolved | 2017-09-04 | 2017-11-16 | 20869 |
APO-QUININE | 300MG | CAPSULE | Resolved | 2017-09-04 | 2018-04-17 | 20894 |
APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2017-09-04 | 2017-11-09 | 20897 |
APO-RIVASTIGMINE | 1.5MG | CAPSULE | Resolved | 2017-09-04 | 2019-10-15 | 20900 |
APO-SERTRALINE | 100MG | CAPSULE | Resolved | 2017-09-04 | 2017-10-05 | 20903 |
APO-CELECOXIB | 200MG | CAPSULE | Resolved | 2017-09-26 | 2018-02-26 | 23546 |
APO-CLINDAMYCIN | 150MG | CAPSULE | Resolved | 2017-09-26 | 2017-10-12 | 23550 |
APO-PREGABALIN | 150MG | CAPSULE | Resolved | 2017-09-27 | 2017-10-30 | 23623 |
APO-PREGABALIN | 25MG | CAPSULE | Resolved | 2017-09-27 | 2018-01-19 | 23626 |
APO-PREGABALIN | 50MG | CAPSULE | Resolved | 2017-09-27 | 2018-01-19 | 23629 |
APO-RAMIPRIL | 10MG | CAPSULE | Resolved | 2017-09-27 | 2017-12-14 | 23641 |
APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2017-09-27 | 2017-11-09 | 23644 |
APO-SERTRALINE | 100MG | CAPSULE | Resolved | 2017-11-09 | 2018-01-31 | 28709 |
APO-GABAPENTIN | 300MG | CAPSULE | Resolved | 2017-11-09 | 2017-12-19 | 28726 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
IBUPROFEN CAPLETS | 200MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71112 |
ACETAMINOPHEN HEADACHE ULTRA RELIEF | 500MG 65MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71192 |
APO-CEFPROZIL | 250MG | TABLET | Discontinued | 2019-01-04 | 2019-02-21 | 71195 |
ACID REDUCER | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71210 |
APO-LOSARTAN | 100MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71213 |
ACETAMINOPHEN TABLETS USP 500 MG | 500MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71216 |
ACETAMINOPHEN TABLETS USP 325 MG | 325MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71219 |
ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71222 |
ACETAMINOPHEN CAPLETS 500 MG | 500MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71225 |
NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
APO-IRBESARTAN | 75MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71231 |
APO-IRBESARTAN | 150MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71234 |
APO-IRBESARTAN | 300MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71237 |
APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
APO-TELMISARTAN | 40MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71345 |
APO-AMITRIPTYLINE | 10MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71348 |
APO-AMITRIPTYLINE | 25MG | TABLET | Discontinued | 2019-01-04 | 2019-02-13 | 71351 |
APO-AMITRIPTYLINE | 50MG | TABLET | To be discontinued | 2019-01-04 | 2021-06-05 | 71354 |
IBUPROFEN | 200MG | TABLET | Discontinued | 2019-01-07 | 2019-01-07 | 71436 |